Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

SNX2-ABL1 fusion

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

SNX2-ABL1 fusion	Childhood B Acute Lymphoblastic Leukemia	SNX2-ABL1 fusion	Childhood B Acute Lymphoblastic Leukemia	dasatinib Resistant: C4 – Case Studies dasatinib Resistant : C4	dasatinib Resistant: C4 – Case Studies dasatinib Resistant : C4
SNX2-ABL1 fusion	B Acute Lymphoblastic Leukemia	SNX2-ABL1 fusion	B Acute Lymphoblastic Leukemia	imatinib Sensitive: C4 – Case Studies imatinib Sensitive : C4	imatinib Sensitive: C4 – Case Studies imatinib Sensitive : C4
SNX2-ABL1 fusion	Acute Lymphocytic Leukemia	SNX2-ABL1 fusion	Acute Lymphocytic Leukemia	imatinib Resistant: D – Preclinical imatinib Resistant : D	imatinib Resistant: D – Preclinical imatinib Resistant : D
SNX2-ABL1 fusion	Acute Lymphocytic Leukemia	SNX2-ABL1 fusion	Acute Lymphocytic Leukemia	dasatinib Resistant: D – Preclinical dasatinib Resistant : D	dasatinib Resistant: D – Preclinical dasatinib Resistant : D